Holen Sie sich die Stockscreener-App
14.70
1.61%
-0.24
Handel nachbörslich:
14.73
0.03
+0.20%
Schlusskurs vom Vortag:
$14.94
Offen:
$14.83
24-Stunden-Volumen:
78,523
Relative Volume:
0.83
Marktkapitalisierung:
$188.93M
Einnahmen:
$16.96M
Nettoeinkommen (Verlust:
$-23.88M
KGV:
-7.01
EPS:
-2.097
Netto-Cashflow:
$-20.66M
1W Leistung:
-0.81%
1M Leistung:
+3.45%
6M Leistung:
-23.83%
1J Leistung:
-24.15%
1-Tages-Spanne:
$14.50
$14.90
1-Wochen-Bereich:
$14.50
$15.24
52-Wochen-Spanne:
$13.54
$21.25
Mediwound Ltd Stock (MDWD) Company Profile
Compare MDWD vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDWD
Mediwound Ltd
|
14.70 | 192.01M | 16.96M | -23.88M | -20.66M | -2.097 |
VRTX
Vertex Pharmaceuticals Inc
|
498.43 | 132.55B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
662.88 | 70.90B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
915.30 | 57.21B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
323.50 | 42.94B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
189.77 | 40.49B | 742.00K | -1.37B | -1.07B | -7.0731 |
Mediwound Ltd Stock (MDWD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-05-02 | Eingeleitet | Alliance Global Partners | Buy |
| 2025-02-28 | Eingeleitet | Craig Hallum | Buy |
| 2024-07-16 | Bestätigt | Maxim Group | Buy |
| 2022-12-22 | Eingeleitet | Maxim Group | Buy |
| 2022-07-18 | Fortgesetzt | Oppenheimer | Outperform |
| 2020-09-23 | Eingeleitet | BTIG Research | Buy |
| 2016-11-28 | Eingeleitet | Aegis Capital | Buy |
| 2016-08-17 | Eingeleitet | Wells Fargo | Outperform |
| 2014-04-16 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Mediwound Ltd Aktie (MDWD) Neueste Nachrichten
(MDWD) Volatility Zones as Tactical Triggers - Stock Traders Daily
Enterprise value to EBITDA forward of MediWound Ltd. – NASDAQ:MDWD - TradingView
MDWDMediWound Ltd Volatility & Greeks - Finviz
Enterprise value to revenue forward of MediWound Ltd. – FWB:M8W - TradingView
MediWound Ltd.(NasdaqGM: MDWD) added to Russell 2000 Value-Defensive Index - marketscreener.com
MediWound Ltd.(NasdaqGM: MDWD) added to Russell 2000 Growth-Defensive Index - marketscreener.com
Price-Driven Insight from (MDWD) for Rule-Based Strategy - Stock Traders Daily
Mediwound Ltd (MDWD) Valuation: PE, PB & Fair Value Analysis - TradingKey
M8W Forecast — Price Target — Prediction for 2027 - TradingView
MediWound Ltd. Actuals & Estimates (NASDAQ:MDWD) - TradingView
Enterprise value to EBITDA forward of MediWound Ltd. – SWB:M8W - TradingView
MDWD Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of MediWound Ltd. – NASDAQ:MDWD - TradingView
Price to earnings forward of MediWound Ltd. – SWB:M8W - TradingView
Price to book forward of MediWound Ltd. – SWB:M8W - TradingView
Mediwound Ltd (MDWD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Mediwound Ltd (MDWD) Institutional Confidence - TradingKey
MediWound (MDWD) Holds Near Support After Marginal Gain, Biotech Sector in FocusCall Resistance - dars.gov.et
Mediwound Ltd (MDWD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Mediwound Ltd (MDWD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Mediwound Ltd (MDWD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Mediwound Ltd (MDWD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mediwound Ltd (MDWD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Mediwound Ltd (MDWD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
MDWD Q1 2026 Earnings: EPS Beat Driven by Operational ImprovementsNet Income Trends - dars.gov.et
MDWD Q1 2026 Earnings: Narrower-Than-Expected Loss Boosts SentimentEarnings Growth Analysis - newsline.com
MDWD Q1 2026 Earnings: Strong Beat on EPS Despite Narrower LossEarnings Per Share - newsline.com
MDWD Q1 2026 Earnings: Significant EPS Beat Drives Positive Sentiment Despite Absent RevenueCost Structure Review - newsline.com
MediWound Ltd. (MDWD) Q1 2026 Earnings: Narrowed Loss Surprises to the UpsideGeographic Revenue Trends - newsline.com
MediWound (MDWD) Sheds 1.87% as Stock Holds Above Key Support LevelAccumulation Line - newsline.com
MediWound Ltd. (MDWD) Retreats 1.87% as Price Tests Support Near $13.47Wave Equality - newsline.com
(MDWD) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Craig Hallum Forecasts MediWound's Q3 Earnings (NASDAQ:MDWD) - MarketBeat
Maxim Group Issues Negative Estimate for MediWound Earnings - MarketBeat
Insider Buying: Nachum Shamir Acquires 6,000 Shares of MediWound Ltd (MDWD) - GuruFocus
Director at MediWound (MDWD) buys 6,000 ordinary shares in market - Stock Titan
MediWound Ltd. Stock Plummets to New 52-Week Low of $13.58 - Markets Mojo
Insider Buying: David Fox Acquires Shares of MediWound Ltd (MDWD) - GuruFocus
Maxim Group Maintains MediWound(MDWD.US) With Buy Rating, Maintains Target Price $30 - Moomoo
MediWound (MDWD) director buys 3,537 ordinary shares on open market - Stock Titan
MediWound Q1 earnings call highlights - MSN
Director Rubinstein buys MediWound (MDWD) shares and holds multiple options - Stock Titan
MediWound Shares Slide This Week; BARDA Moves in Focus - Bez Kabli
MediWound Ltd. Hits New 52-Week Low at USD 14.14 - MarketsMojo
MediWound Ltd. (MDWD) Q1 2026 Earnings: Significant EPS Beat Highlights Cost DisciplineGrowth Acceleration Report - dars.gov.et
MediWound (MDWD) Slips 1.58% as Stock Holds Near Critical Support at $13.61Price Momentum Stocks - The Legal Advocate
5 Stocks Better Than MediWound as Q1 Revenue Declines - HarianBasis.co
A. G. P. Maintains MediWound(MDWD.US) With Buy Rating, Cuts Target Price to $22 - Moomoo
MDWD Maintains Outperform by Oppenheimer -- Price Target Lowered to $32 - GuruFocus
MDWD Reiterates by HC Wainwright & Co. -- Price Target Maintained at $36 - GuruFocus
Finanzdaten der Mediwound Ltd-Aktie (MDWD)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.27%
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):